NPs Basic Information

Name
tardioxopiperazine B
Molecular Formula C24H31N3O2
IUPAC Name*
(3S,6S)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-7-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]piperazine-2,5-dione
SMILES
C[C@H]1C(=O)N[C@H](C(=O)N1)CC2=C(NC3=C(C=CC=C23)CC=C(C)C)C(C)(C)C=C
InChI
InChI=1S/C24H31N3O2/c1-7-24(5,6)21-18(13-19-23(29)25-15(4)22(28)26-19)17-10-8-9-16(20(17)27-21)12-11-14(2)3/h7-11,15,19,27H,1,12-13H2,2-6H3,(H,25,29)(H,26,28)/t15-,19-/m0/s1
InChIKey
QNQMVKRHUCFRIY-KXBFYZLASA-N
Synonyms
tardioxopiperazine B; CHEMBL249257; CHEBI:193006; cyclo-L-2-tert-DMA-7-DMA-Trp-L-Ala; 2-(1,1-Dimethyl-2-propenyl)-7-isopentenylcyclo(L-Trp-L-Ala-)
CAS NA
PubChem CID 10810597
ChEMBL ID CHEMBL249257
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic acids and derivat
      • Class: Carboxylic acids and deri
        • Subclass: Amino acids, peptides, an
          • Direct Parent: Alpha amino acids and der

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 393.5 ALogp: 5.1
HBD: 3 HBA: 2
Rotatable Bonds: 6 Lipinski's rule of five: Accepted
Polar Surface Area: 74.0 Aromatic Rings: 3
Heavy Atoms: 29 QED Weighted: 0.637

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.848 MDCK Permeability: 0.00001320
Pgp-inhibitor: 0.981 Pgp-substrate: 0.05
Human Intestinal Absorption (HIA): 0.037 20% Bioavailability (F20%): 0.91
30% Bioavailability (F30%): 0.095

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.771 Plasma Protein Binding (PPB): 93.29%
Volume Distribution (VD): 0.962 Fu: 3.47%

ADMET: Metabolism

CYP1A2-inhibitor: 0.301 CYP1A2-substrate: 0.316
CYP2C19-inhibitor: 0.909 CYP2C19-substrate: 0.123
CYP2C9-inhibitor: 0.719 CYP2C9-substrate: 0.557
CYP2D6-inhibitor: 0.749 CYP2D6-substrate: 0.648
CYP3A4-inhibitor: 0.944 CYP3A4-substrate: 0.501

ADMET: Excretion

Clearance (CL): 1.813 Half-life (T1/2): 0.164

ADMET: Toxicity

hERG Blockers: 0.056 Human Hepatotoxicity (H-HT): 0.505
Drug-inuced Liver Injury (DILI): 0.838 AMES Toxicity: 0.013
Rat Oral Acute Toxicity: 0.913 Maximum Recommended Daily Dose: 0.267
Skin Sensitization: 0.113 Carcinogencity: 0.078
Eye Corrosion: 0.003 Eye Irritation: 0.009
Respiratory Toxicity: 0.979
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002068 0.756 D0N1WU 0.232
ENC000859 0.693 D0O6KE 0.220
ENC003867 0.673 D0W7WC 0.217
ENC003866 0.673 D01AYJ 0.216
ENC002460 0.663 D0Q0PR 0.215
ENC002631 0.648 D0B4DC 0.205
ENC001987 0.640 D0W6DG 0.202
ENC002896 0.596 D0NG7O 0.198
ENC003796 0.573 D0H5MB 0.197
ENC002630 0.505 D0WN0U 0.197
*Note: the compound similarity was calculated by RDKIT.